Medicared For All Logo

Orit Markowitz in New York, New York

Home New York New York

Orit Markowitz has Dermatology as her primary medical specialty. Their primary office is: 1150 5th Ave in New York, New York. They attended Drexel University College Of Medicine and graduated in 2003 (around 22 years of experience). They are listed as doing telehealth appointments.


Orit Markowitz Office Phone and Directions

Orit Markowitz
1150 5th Ave
New York, New York 10128
347-881-3392


Patient Ratings
Please rate your experience with Orit Markowitz below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 347-881-3392


Enter a starting address:


Healthcare Info for Orit Markowitz

Medical School: Drexel University College Of Medicine
Graduation Year: 2003
The Primary Medical Specialty for Orit Markowitz is listed as: Dermatology
Approximate Years of Experience: 22
PAC (PECOS ID)#: 7315024890
NPI #: 1215121538
NPI Created On: 08/29/2007
NPI Last Updated Listed as: 03/17/2008
Primary Taxonomy Code: 207N00000X
License Number:
240489
Listed Gender: Female

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Humana
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.


Services and Procedures include:

  1. Acne surgery
  2. Tangential biopsy of single skin lesion
  3. Tangential biopsy of additional skin lesion
  4. Destruction of skin growth
  5. Destruction of 2-14 skin growths
  6. Destruction of up to 14 skin growths
  7. Destruction of 15 or more skin growths
  8. Destruction of malignant growth (0.5 centimeters or less) of trunk, arms, or legs
  9. Destruction of malignant growth (0.6 to 1.0 centimeters) of trunk, arms, or legs
  10. Destruction of malignant growth (0.6 to 1.0 centimeters) of face, ears, eyelids, nose, lips, or mouth
  11. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
  12. Application of light and light-sensitive drugs following removal of premalignant thickened skin growth, per day
  13. Microscopy of lesion of skin with interpretation and report - first lesion
  14. Established patient office or other outpatient visit, typically 10 minutes
  15. Established patient office or other outpatient visit, typically 15 minutes
  16. Established patient office or other outpatient, visit typically 25 minutes
  17. Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787994357

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Immunology

Name of Drug #1: REMICADE

Open Associated Drug #1: 57894-030-01

Drug or Biological: Biological

Product Category #2: Immunology

Name Of Drug #2:: STELARA

Associated Drug #2: 57894-060-03

Drug or Biological #3:: Biological

Product Category #3: Immunology

Name of Drug: SIMPONI ARIA

Name Of Drug #3: 57894-350-01

Drug or Biological: Biological

Product Category #4: Immunology

Name of Drug #4: SIMPONI

Associated Drug #4: 57894-070-01


Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787994359

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Immunology

Name of Drug #1: REMICADE

Open Associated Drug #1: 57894-030-01

Drug or Biological: Biological

Product Category #2: Immunology

Name Of Drug #2:: STELARA

Associated Drug #2: 57894-060-03

Drug or Biological #3:: Biological

Product Category #3: Immunology

Name of Drug: SIMPONI ARIA

Name Of Drug #3: 57894-350-01

Drug or Biological: Biological

Product Category #4: Immunology

Name of Drug #4: SIMPONI

Associated Drug #4: 57894-070-01


Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787994361

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Immunology

Name of Drug #1: TREMFYA

Open Associated Drug #1: 57894-640-01


Payments Total: $28

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787994363

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Immunology

Name of Drug #1: TREMFYA

Open Associated Drug #1: 57894-640-01


Payments Total: $40

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787994365

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Immunology

Name of Drug #1: TREMFYA

Open Associated Drug #1: 57894-640-01


Payments Total: $38

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787994367

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Immunology

Name of Drug #1: TREMFYA

Open Associated Drug #1: 57894-640-01


Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787994369

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Immunology

Name of Drug #1: TREMFYA

Open Associated Drug #1: 57894-640-01


Payments Total: $25

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 819746843

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: VALCHLOR

Open Associated Drug #1: 66215-016-60


Payments Total: $19

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 819698857

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Dermatology

Name of Drug #1: Seysara

Open Associated Drug #1: 16110-247-30


Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest: Yes

Third party is a Charity:: No

Record ID:: 835959949

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: BioOncology

Name of Drug #1: Erivedge

Open Associated Drug #1: 50242-140-01


Dermatology Professionals in New York

1901 1st Ave
New-york, NY
Metropolitan Medical Practice Plan Pc

30 -32 Ericsson Place
New-york, NY
Adam Geyer Md Pc

1305 York Ave
New-york, NY
Weill Medical College Of Cornell

525 E 68th St
New-york, NY
Weill Medical College Of Cornell

111 Broadway
New-york, NY
New York University

975 Park Ave
New-york, NY

Providers in the same medical group

1.Jon Aagaard

2001 N Gary Ave
Wheaton Il 60187-3055
Family Practice

2.Matthew Aaker

8055 W Ave
Castle Hills Tx 78213-1842
Optometry

3.Justin Aaker

3613 Williams Dr
Georgetown Tx 78628-1373
Ophthalmology

4.Mohammad Aalai

7005 35th Ave
Jackson Heights Ny 11372-3970
Physical Medicine And Rehabilitation

5.Carol Aalbers Cp

4560 S Carson St
Carson City Nv 89701-6915
Clinical Psychologist

6.Hina Aamir

602 S Atwood Rd
Bel Air Md 21014-4323
Psychiatry